TAMPA, Fla., April 16, 2021 /PRNewswire/ -- Tampa General Hospital announced today Eduardo M. Sotomayor, MD, as the director of its newly established Cancer Institute to provide world-class, innovative cancer care in one of Florida's leading academic medical centers. Internationally recognized as a pioneer in the field of cancer immunology and immunotherapy and a renowned expert in lymphoma research and treatment, Sotomayor will lead a team of accomplished TGH cancer specialists who will further develop the hospital's cancer clinical care and clinical research services to provide next-generation care and multidisciplinary treatment.

Dr. Eduardo M. Sotomayor to Lead New TGH Cancer Institute
Sotomayor joins Tampa General from the George Washington University Cancer Center in Washington, DC, where he directed all cancer care and research activities during the past five years. His ongoing research in cancer immunology and immunotherapy focuses on developing novel, immune-based approaches for the treatment of lymphomas and other hematologic malignancies. He is an internationally renowned expert in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin's lymphoma. Previously, Sotomayor held leadership roles in some of the country's nationally ranked cancer programs.

"Dr. Sotomayor is an outstanding clinician and researcher, and we are thrilled to welcome him to the Tampa General team," said John Couris, president and chief executive officer. "His expertise will help provide an even more sophisticated level of treatment at Tampa General and will ensure we continue to deliver the safest and most innovative care for our cancer patients and their families."

Building on the success of the Tampa General Hospital oncology program -- rated among the top 10 percent for cancer care in the U.S. according to U.S. News & World Report's 2020-2021 rankings -- the new Tampa General Hospital Cancer Institute will provide comprehensive care via groundbreaking therapies and advanced diagnostic imaging tools. Sotomayor joins nationally recognized radiation oncologist and researcher Richard Tuli, MD, PhD, who recently joined the team from Memorial Sloan Kettering Cancer Center, to pursue cutting-edge treatments that offer comprehensive and personalized care to patients.

"I'm honored and thrilled to return back home to join the impressive and forward-thinking Tampa General team and look forward to building an innovative Cancer Institute together," said Sotomayor. "Our priority is to use the latest research and therapies to provide the best care to patients in Florida and beyond, with special emphasis in breaking the barriers to access to cancer care to the community we serve."

More People on the Move